Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure.
Correlates and predictors of patient satisfaction with drug therapy and combined drug therapy and behavioral training for urgency urinary incontinence in women.
Neuroticism
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement.
Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.
Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice. Blood. 2019 01 17; 133(3):193-204.
View in:
PubMed
subject areas
Adult
Animals
Anticoagulants
Apoptosis Regulatory Proteins
Blood Coagulation
Case-Control Studies
Cerebral Hemorrhage
Endothelial Protein C Receptor
Endothelium, Vascular
Hemangioma, Cavernous, Central Nervous System
Humans
KRIT1 Protein
Membrane Proteins
Mice
Mice, Knockout
Protein C
Proto-Oncogene Proteins
Signal Transduction
Thrombomodulin
Young Adult
authors with profiles
Issam Awad
Romuald Girard
Sean Polster